Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Hematology|March 15, 2023
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)Hiroyasu Ishikura, Junichi Maruyama, Maiko Nakashio, et al.
The Journal of Biological Chemistry|August 24, 2012
Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5Shiori Sekine, Yusuke Kanamaru, Masato Koike, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 8, 2020
Assessment of suitable antihypertensive therapies: Combination with high-dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI-AI study)Naoki Nakagawa, Nobuyuki Sato, Yasuaki Saijo, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|October 15, 2021
Characterization of mouse embryonic fibroblasts derived from Rassf6 knockout mice shows the implication of Rassf6 in the regulation of NF-κB signalingMayu Morishita, Kyoko Arimoto-Matsuzaki, Masami Kitamura, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 13, 2021
SARS-CoV-2 is localized in cardiomyocytes: a postmortem biopsy caseYoshihiko Nakamura, Harutaka Katano, Noriko Nakajima, et al.
Journal of Hypertension|March 16, 2013
Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 yearNobuyuki Sato, Yasuaki Saijo, Yutaka Sasagawa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 10, 2015
Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysisNobuyuki Sato, Yasuaki Saijo, Yutaka Sasagawa, et al.
Pageof 6